Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline plc - ADR Company Snapshot
GlaxoSmithKline plc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other companies in this sector in the United States: Sanofi S.A. (2016 sales of $38.31 billion of which 84% was Pharmaceuticals), Abbvie Inc ($25.64 billion of which 100% was Pharmaceutical Products), and Merck & Co. , Inc. ($39.81 billion of which 88% was Merck Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at GlaxoSmithKline plc were $37.50 billion. This is an increase of 2.8% versus 2015, when the company's sales were $36.48 billion. Despite this increase, sales are still slightly below the level achieved in 2014, when GlaxoSmithKline plc reported sales of $37.87 billion. Sales of Vaccines saw an increase that was more than double the company's growth rate: sales were up 10.7% in 2016, from $5.58 billion to $6.17 billion. GlaxoSmithKline plc also saw significant increases in sales in Consumer Healthcare (up 5.2% to $9.67 billion) .
  Stock Performance Chart for GlaxoSmithKline plc - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/15/2017): 34.99
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks -0.2%  
4 Weeks -13.0%   52 Weeks -9.2%  
GlaxoSmithKline plc - ADR Key Data:
  Ticker: GSK Country: United States
  Exchanges: NYSE FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 37,495,923,830
(Year Ending Jan 2017).
Employees: 99,827
  Currency: U.S. Dollars Market Cap: 86,052,336,586
  Fiscal Yr Ends: December Shares Outstanding: 2,459,340,857
  Share Type: Ordinary Closely Held Shares: 28,209,306
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.